Ebanga Injection, Powder, Lyophilized, For Solution
Product Images NDC 71655-578
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ebanga (NDC 71655-578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Emergent Manufacturing Operations Baltimore, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ebanga (Ebanga 02)
400 mg Vial Label (Ebanga 03)
This text is a pharmaceutical label for the medication Ebanga (ansuvimab-zykl) for Injection. Each vial contains 400 mg of the medication for intravenous use. It provides instructions on reconstitution, dilution, storage conditions (2°C to 8°C), and not freezing or shaking the product. The label also includes information on prescribing dosage, single-dose vial usage, and discarding unused portions. Manufacturing details are provided by Emergent Manufacturing Operations in Baltimore, Maryland, with a US License No. 2083.*
Carton Containing 36x400 mg Vials (Ebanga 04)
Box Containing Single Carton (Ebanga 05)
Box Containing 4 Cartons (Ebanga 06)
Box Containing 8 Cartons (Ebanga 07)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.